Cover Image
市場調查報告書

印度的醫藥品研究開發及受託製造服務(CRAMS)市場

Contract Research and Manufacturing (CRAMS) Service Market in India 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 310803
出版日期 內容資訊 英文 48 Pages
訂單完成後即時交付
價格
Back to Top
印度的醫藥品研究開發及受託製造服務(CRAMS)市場 Contract Research and Manufacturing (CRAMS) Service Market in India 2014-2018
出版日期: 2014年08月20日 內容資訊: 英文 48 Pages
簡介

所謂醫藥品研究開發及受託製造服務(CRAMS),是定義為外包給可提供低價格研究開發服務/製造活動的組織的流程。CRAMS基本由受託研究開發和受託製造2個活動構成。CRAMS主要用於需大範圍的R&D及大規模的製造設備的醫藥品、生物科技部門。印度的CRAMS市場在2013-2018年期間,預計以32.67%的CAGR成長。

本報告提供印度的醫藥品研究開發及受託製造服務(CRAMS)市場相關分析、市場規模與成長率、市場趨勢、推動市場要素、課題、市場機會驗證、主要供應商等相關的系統性資訊。

第1章 摘要整理

第2章 簡稱集

第3章 調查範圍

  • 市場概要
  • 提供產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場形勢

  • 市場概要
  • 市場規模與預測

第7章 印度的CRAMS市場優點分析

  • 波特的五力分析

第8章 市場區隔:各分類

  • 印度的醫藥品受託研究開發市場
  • 印度的醫藥品受託製造市場

第9章 購買標準

第10章 推動市場成長要素

第11章 推動市場成長要素與其影響

第12章 市場課題

第13章 推動市場成長要素、課題

第14章 市場趨勢

第15章 趨勢與其影響

第16章 業者情勢

  • 競爭情形
  • 市場佔有率分析
  • 其他有潛力的供應商

第18章 主要供應商分析

  • Biocon Ltd.
    • 產業概要
    • 產業區分
    • 主要資訊
    • SWOT分析
  • Dishman Pharmaceuticals and Chemicals Ltd.
  • Divis Laboratories Ltd.
  • Jubilant Life Sciences Ltd.
  • Piramal Healthcare Ltd.

第19章 其他相關報告

圖表清單

目錄
Product Code: IRTNTR3918

About CRAMS

CRAMS is defined as the process of outsourcing research services/ product manufacturing activities to organizations which can provide the service at a low cost. CRAMS basically consists of the following two activities: contract research and contract manufacturing. CRAMS is mainly used in the Pharmaceutical and Biotechnology sectors that require extensive R&D and large-scale manufacturing facilities. It is expected that the demand for contract research and contract manufacturing is expected to increase in India in the future.

TechNavio's analysts forecast the CRAMS market in India to grow at a CAGR of 32.67 percent over the period 2013-2018.

Covered in this Report

In terms of activities, the CRAMS market in India can be segmented into two: Contract Research and Contract Manufacturing. To calculate the market size, the report considers the revenue generated from the services offered by contract research and contract manufacturing organizations to other equipment manufacturers (OEMs) for the manufacturing of new chemical entities, API, and pre-clinical and clinical research.

TechNavio's report, the CRAMS Market in India 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the CRAMS market in India and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • India

Key Vendors

  • Biocon
  • Dishman Pharmaceuticals and Chemicals
  • Divis Laboratories
  • Jubilant Life Sciences
  • Piramal Healthcare

Other Prominent Vendors

  • Aurbindo Pharma
  • Cadila Healthcare
  • Dr. Reddy's Laboratories
  • GVK Biosciences
  • Ipca Laboratories
  • Lupin
  • Quintiles
  • Siro Clinpharm
  • Sun Pharmaceutical
  • Wockhardt

Market Driver

  • Rising Cost of Research in Developed Markets

For a full, detailed list, view our report

Market Challenge

  • Growing Global Competition

For a full, detailed list, view our report

Market Trend

  • Increase in Strategic Alliances

For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast

07. Benefit Analysis of CRAMS Market in India

  • 07.1. Five Forces Analysis

08. Market Segmentation by Category

  • 08.1. Contract Research Market in India
    • 08.1.1. Market Size and Forecast
  • 08.2. Contract Manufacturing Market in India
    • 08.2.1. Market Size and Forecast

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

  • 16.1. Competitive Scenario
    • 16.1.1. Key News
    • 16.1.2. Mergers and Acquisitions
  • 16.2. Market Share Analysis 2013
  • 16.3. Other Prominent Vendors

17. Competitive Assessment of Major Players

18. Key Vendor Analysis

  • 18.1. Biocon Ltd.
    • 18.1.1. Business Overview
    • 18.1.2. Business Segmentation
    • 18.1.3. Key Information
    • 18.1.4. SWOT Analysis
  • 18.2. Dishman Pharmaceuticals and Chemicals Ltd.
    • 18.2.1. Business Overview
    • 18.2.2. Business Segmentation
    • 18.2.3. Key Information
    • 18.2.4. SWOT Analysis
  • 18.3. Divis Laboratories Ltd.
    • 18.3.1. Business Overview
    • 18.3.2. Key Information
    • 18.3.3. SWOT Analysis
  • 18.4. Jubilant Life Sciences Ltd.
    • 18.4.1. Business Overview
    • 18.4.2. Business Segmentation
    • 18.4.3. Key Information
    • 18.4.4. SWOT Analysis
  • 18.5. Piramal Healthcare Ltd.
    • 18.5.1. Business Overview
    • 18.5.2. Key Information
    • 18.5.3. SWOT Analysis

19. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: CRAMS Market in India 2013-2018 (US$ billion)
  • Exhibit 3: CRAMS Market in India Segmentation by Category
  • Exhibit 4: CRAMS Market in India by Market Segmentation 2013
  • Exhibit 5: Contract Research Market in India 2013-2018 (US$ billion)
  • Exhibit 6: Contract Manufacturing Market in India 2013-2108 (US$ billion)
  • Exhibit 7: CRAMS Market in India Segmentation by Category 2013-2018 (US$ billion)
  • Exhibit 8: CRAMS Market in India Segmentation by Category 2013-2018 (in percent)
  • Exhibit 9: Business Segmentation of Biocon Ltd.
  • Exhibit 10: Business Segmentation of Dishman Pharmaceuticals and Chemicals Ltd.
  • Exhibit 11: Business Segmentation of Jubiliant Life Sciences Ltd.
Back to Top